Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000954227 | SCV001100846 | benign | Congenital disorder of glycosylation, type IIq | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001766797 | SCV002008000 | likely benign | not provided | 2019-09-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001766797 | SCV004126086 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | COG2: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV001766797 | SCV005264338 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004758104 | SCV005352131 | benign | COG2-related disorder | 2024-08-22 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |